Transcatheter Aortic Valve Replacement and Impact of Subclinical Leaflet Thrombosis in Low-Risk Patients: LRT Trial 4-Year Outcomes.
Ron WaksmanSukhdeep BhogalPaul GordonAfshin EhsanSean R WilsonRobert LevittPuja B ParikhThomas V BilfingerNicholas HannaMaurice BuchbinderFederico M AschFrancis Y KimGaby WeissmanItsik Ben-DorChristian C ShultsSyed AliJoseph A SuttonCorey SheaCheng ZhangLuis A Mansilla ÁlvarezLowell F SatlerToby RogersPublished in: Circulation. Cardiovascular interventions (2023)
gov; Unique identifier: NCT02628899.
Keyphrases
- transcatheter aortic valve replacement
- aortic valve
- aortic stenosis
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- clinical trial
- pulmonary embolism
- mitral valve
- type diabetes
- prognostic factors
- study protocol
- metabolic syndrome
- phase ii
- atrial fibrillation
- left ventricular
- adipose tissue